Cargando…

A Scalable Topical Vectored Vaccine Candidate against SARS-CoV-2

The severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) caused an ongoing unprecedented global public health crises of coronavirus disease in 2019 (CoVID-19). The precipitously increased death rates, its impact on livelihood and trembling economies warrant the urgent development of a SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rohaim, Mohammed A., Munir, Muhammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565466/ https://www.ncbi.nlm.nih.gov/pubmed/32846910 http://dx.doi.org/10.3390/vaccines8030472

Ejemplares similares

Avian Orthoavulavirus Type-1 as Vaccine Vector against Respiratory Viral Pathogens in Animal and Human
por: Vilela, Julianne, et al.
Publicado: (2022)

Structural topological analysis of spike proteins of SARS-CoV-2 variants of concern highlight distinctive amino acid substitution patterns
por: Peisahovics, Filips, et al.
Publicado: (2022)

Immunogenicity and protective efficacy of an intranasal live-attenuated vaccine against SARS-CoV-2
por: Park, Jun-Gyu, et al.
Publicado: (2021)

Scalable live-attenuated SARS-CoV-2 vaccine candidate demonstrates preclinical safety and efficacy
por: Wang, Ying, et al.
Publicado: (2021)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine candidate is protective in macaques
por: Nouën, Cyril Le, et al.
Publicado: (2022)

Development of DNA Vaccine Candidate against SARS-CoV-2
por: Wang, Xingyun, et al.
Publicado: (2022)

Identification of synthetic vaccine candidates against SARS CoV infection
por: Lien, Shu-Pei, et al.
Publicado: (2007)

A candidate multi-epitope vaccine against SARS-CoV-2
por: Kar, Tamalika, et al.
Publicado: (2020)

Mapping molecular gene signatures mediated by SARS-COV-2 and large-scale and genome-wide transcriptomics comparative analysis among respiratory viruses of medical importance
por: Smith, Thomas, et al.
Publicado: (2022)

Simultaneous Deletion of Virulence Factors and Insertion of Antigens into the Infectious Laryngotracheitis Virus Using NHEJ-CRISPR/Cas9 and Cre–Lox System for Construction of a Stable Vaccine Vector
por: Atasoy, Mustafa Ozan, et al.
Publicado: (2019)

A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
por: Mohsen, Mona O., et al.
Publicado: (2021)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Development of an Integrated Continuous Manufacturing Process for the rVSV-Vectored SARS-CoV-2 Candidate Vaccine
por: Yang, Zeyu, et al.
Publicado: (2023)

Intranasal administration of cold-adapted live-attenuated SARS-CoV-2 candidate vaccine confers protection against SARS-CoV-2
por: Abdoli, Mohsen, et al.
Publicado: (2022)

Immunogenic potential of DNA vaccine candidate, ZyCoV-D against SARS-CoV-2 in animal models
por: Dey, Ayan, et al.
Publicado: (2021)

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
por: Shepherd, Sarah J., et al.
Publicado: (2023)

Vaccination of cats with Sad23L-nCoV-S vaccine candidate against major variants of SARS-CoV-2
por: Zhang, Panli, et al.
Publicado: (2022)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Candidate drugs against SARS-CoV-2 and COVID-19
por: McKee, Dwight L., et al.
Publicado: (2020)

Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2
por: Wang, Hui, et al.
Publicado: (2020)

A systematic review of SARS-CoV-2 vaccine candidates
por: Dong, Yetian, et al.
Publicado: (2020)

MVA-CoV2-S Vaccine Candidate Neutralizes Distinct Variants of Concern and Protects Against SARS-CoV-2 Infection in Hamsters
por: Boudewijns, Robbert, et al.
Publicado: (2022)

Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic
por: Mendonça, Samir Andrade, et al.
Publicado: (2021)

Bioinformatics Analysis of SARS-CoV-2 to Approach an Effective Vaccine Candidate Against COVID-19
por: Sadat, Seyed Mehdi, et al.
Publicado: (2021)

Preclinical evaluation of a candidate naked plasmid DNA vaccine against SARS-CoV-2
por: Lassaunière, Ria, et al.
Publicado: (2021)

Identification of vaccine candidate against Omicron variant of SARS-CoV-2 using immunoinformatic approaches
por: Aasim, et al.
Publicado: (2022)

Application of CRISPR/Cas9 in Understanding Avian Viruses and Developing Poultry Vaccines
por: Vilela, Julianne, et al.
Publicado: (2020)

Immune Thrombocytopenia Induced by the Chimpanzee Adenovirus-Vectored Vaccine against SARS-CoV-2 Infection
por: Liao, Po-Wei, et al.
Publicado: (2021)

In vitro efficacy of topical ophthalmic antiseptics against SARS-CoV-2
por: Felfeli, Tina, et al.
Publicado: (2021)

Protein-based nano-vaccines against SARS-CoV-2: Current design strategies and advances of candidate vaccines
por: Wang, Dongliang, et al.
Publicado: (2023)

Biodistribution and environmental safety of a live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate
por: Li, Li-Hsin, et al.
Publicado: (2022)

Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates
por: Prenafeta, Antoni, et al.
Publicado: (2023)

Intranasal pediatric parainfluenza virus-vectored SARS-CoV-2 vaccine is protective in monkeys
por: Le Nouën, Cyril, et al.
Publicado: (2022)

Timing vaccination against SARS-CoV-2
por: Barnoud, Coline, et al.
Publicado: (2021)

Ebselen, a new candidate therapeutic against SARS-CoV-2
por: Haritha, C.V., et al.
Publicado: (2020)

Antivirals Against Coronaviruses: Candidate Drugs for SARS-CoV-2 Treatment?
por: Santos, Igor de Andrade, et al.
Publicado: (2020)

A SARS-CoV-2 vaccine candidate: In-silico cloning and validation
por: Bhattacharya, Manojit, et al.
Publicado: (2020)

SARS-CoV-2–Specific Vaccine Candidates; the Contribution of Structural Vaccinology
por: Pack, Su Min, et al.
Publicado: (2022)

Design an Efficient Multi-Epitope Peptide Vaccine Candidate Against SARS-CoV-2: An in silico Analysis
por: Yazdani, Zahra, et al.
Publicado: (2020)

Insights from the Construction of Adenovirus-Based Vaccine Candidates against SARS-CoV-2: Expecting the Unexpected
por: Weklak, Denice, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s05i0qtihmi1klpo09qhpdp5ff